China Peritoneal Dialysis Market
Description
China Peritoneal Dialysis Market size was valued at USD 1.2 billion in 2023 and is poised to grow from USD 1.47 billion in 2024 to USD 2.64 billion by 2032, growing at a CAGR of 8.7% during the forecast period (2024-2032).
The increasing prevalence of chronic kidney diseases (CKD), especially end-stage renal disease (ESRD), driven by rising diabetic nephropathy and hypertension cases in China, is fueling robust growth in the peritoneal dialysis (PD) market. The market expansion is supported by government-backed initiatives such as the "Healthy China 2030" plan, which promotes home-based dialysis therapies to alleviate hospital infrastructure pressures and provide patients with more flexible treatment options. Guangdong province leads the market with its developed healthcare infrastructure and early adoption of home dialysis programs, while regions like Hong Kong exemplify success with their established PD-first policies servicing a significant population share. Technological advancements—including automated peritoneal dialysis (APD) machines, biocompatible dialysate solutions, and telehealth-enabled remote monitoring—enhance treatment efficacy and convenience. Additionally, rising investments in digital health platforms and supply chain integration through e-commerce partnerships are facilitating broader PD adoption, especially in rural and underserved areas.
China Peritoneal Dialysis Market Segments Analysis
Global China Peritoneal Dialysis Market is segmented by Offering, Dialysis Type, Indication, End User, and Region. Based on Offerings, the market is divided into Product (dialysis machines, dialysis bags, catheters, transfer sets, others) and Services. Based on Dialysis Type, it includes Continuous Ambulatory Peritoneal Dialysis (CAPD) and Automated Peritoneal Dialysis (APD). Based on Indication, segmentation covers End-Stage Renal Disease (ESRD), Acute Kidney Injury (AKI), and Chronic Kidney Disease (CKD). Based on End User, the market segments include Hospitals, Dialysis Centers & Clinics, Homecare Settings, and Others. Regionally, the market is segmented by provinces such as Guangdong, Shanghai, Beijing, Tianjin, Zhejiang, Fujian, Chongqing, Sichuan, Hong Kong SAR, Jiangsu, and Rest of China.
Driver of the China Peritoneal Dialysis Market
A primary driver of the China PD market is the surging incidence of CKD and ESRD, catalyzed by increasing diabetes and hypertension prevalence. Government initiatives promoting home-based dialysis under "Healthy China 2030" reduce healthcare burden and increase accessibility. Technological innovation in PD fluids, automated systems, and telemedicine enhances clinical outcomes and patient compliance. Expansion of healthcare infrastructure in tier 2/3 cities and targeted reimbursement policies also support market growth.
Restraints in the China Peritoneal Dialysis Market
Key restraints include the risk of peritonitis and other infections that undermine patient confidence and hinder adoption. Regional disparities in healthcare infrastructure and PD quality, alongside regulatory hurdles and uneven reimbursement coverage, pose challenges. Moreover, limited awareness in rural populations and concerns regarding long-term adherence impact growth. The cost and complexity of advanced PD equipment also limit broader penetration.
Market Trends of the China Peritoneal Dialysis Market
Notable trends include increased local manufacturing of PD consumables under government initiatives to reduce costs and supply risks, growing acceptance of APD, integration of telehealth and remote monitoring for patient management, and expansion of e-commerce platforms for supply chain and adherence support. Additionally, sustainability efforts in PD waste management and digital health innovations such as AI-based monitoring are shaping the market’s future.
The increasing prevalence of chronic kidney diseases (CKD), especially end-stage renal disease (ESRD), driven by rising diabetic nephropathy and hypertension cases in China, is fueling robust growth in the peritoneal dialysis (PD) market. The market expansion is supported by government-backed initiatives such as the "Healthy China 2030" plan, which promotes home-based dialysis therapies to alleviate hospital infrastructure pressures and provide patients with more flexible treatment options. Guangdong province leads the market with its developed healthcare infrastructure and early adoption of home dialysis programs, while regions like Hong Kong exemplify success with their established PD-first policies servicing a significant population share. Technological advancements—including automated peritoneal dialysis (APD) machines, biocompatible dialysate solutions, and telehealth-enabled remote monitoring—enhance treatment efficacy and convenience. Additionally, rising investments in digital health platforms and supply chain integration through e-commerce partnerships are facilitating broader PD adoption, especially in rural and underserved areas.
China Peritoneal Dialysis Market Segments Analysis
Global China Peritoneal Dialysis Market is segmented by Offering, Dialysis Type, Indication, End User, and Region. Based on Offerings, the market is divided into Product (dialysis machines, dialysis bags, catheters, transfer sets, others) and Services. Based on Dialysis Type, it includes Continuous Ambulatory Peritoneal Dialysis (CAPD) and Automated Peritoneal Dialysis (APD). Based on Indication, segmentation covers End-Stage Renal Disease (ESRD), Acute Kidney Injury (AKI), and Chronic Kidney Disease (CKD). Based on End User, the market segments include Hospitals, Dialysis Centers & Clinics, Homecare Settings, and Others. Regionally, the market is segmented by provinces such as Guangdong, Shanghai, Beijing, Tianjin, Zhejiang, Fujian, Chongqing, Sichuan, Hong Kong SAR, Jiangsu, and Rest of China.
Driver of the China Peritoneal Dialysis Market
A primary driver of the China PD market is the surging incidence of CKD and ESRD, catalyzed by increasing diabetes and hypertension prevalence. Government initiatives promoting home-based dialysis under "Healthy China 2030" reduce healthcare burden and increase accessibility. Technological innovation in PD fluids, automated systems, and telemedicine enhances clinical outcomes and patient compliance. Expansion of healthcare infrastructure in tier 2/3 cities and targeted reimbursement policies also support market growth.
Restraints in the China Peritoneal Dialysis Market
Key restraints include the risk of peritonitis and other infections that undermine patient confidence and hinder adoption. Regional disparities in healthcare infrastructure and PD quality, alongside regulatory hurdles and uneven reimbursement coverage, pose challenges. Moreover, limited awareness in rural populations and concerns regarding long-term adherence impact growth. The cost and complexity of advanced PD equipment also limit broader penetration.
Market Trends of the China Peritoneal Dialysis Market
Notable trends include increased local manufacturing of PD consumables under government initiatives to reduce costs and supply risks, growing acceptance of APD, integration of telehealth and remote monitoring for patient management, and expansion of e-commerce platforms for supply chain and adherence support. Additionally, sustainability efforts in PD waste management and digital health innovations such as AI-based monitoring are shaping the market’s future.
Table of Contents
260 Pages
- 1. Introduction
- 1.1. Objectives of the Study
- 1.2. Scope of the Report
- 1.3. Definitions
- 2. Research Methodology
- 2.1. Information Procurement
- 2.2. Secondary & Primary Data Methods
- 2.3. Market Size Estimation
- 2.4. Market Assumptions & Limitations
- 3. Executive Summary
- 3.1. China Market Outlook
- 3.3. Segmental Opportunity Analysis
- 4. Market Dynamics & Outlook
- 4.1. Market Overview
- 4.2. Supply & Demand Trend Analysis
- 4.3. Market Dynamics
- 4.3.1. Driver & Opportunities
- 4.3.2. Restraints & Challenges
- 4.4. Porters Analysis & Impact
- 4.4.1. Competitive Rivalry
- 4.4.2. Threat of Substitute
- 4.4.3. Bargaining Power of Buyers
- 4.4.4. Threat of New Entrants
- 4.4.5. Bargaining Power of Suppliers
- 5. Key Market Insights
- 5.1. Key Success Factors
- 5.2. Top Investment Pockets
- 5.3. PESTEL Analysis
- 5.4. Value Chain Analysis
- 5.6. Patent Analysis
- 5.7. Installed Analysis
- 5.8. Case Study Analysis
- 5.9. Technology Analysis
- 5.10. Regulatory Landscape
- 5.11. Pricing Analysis
- 5.12. Ecosystem Analysis
- 5.13. Epidemiology Analysis
- 5.14. Peritoneal Dialysis Volume Analysis
- 6. China Peritoneal Dialysis Market Size By Offerings (2019-2032)
- 6.1. Product
- 6.1.1. Dialysis Machines
- 6.1.2. Dialysis Bags
- 6.1.2.1. Dialysate Solution Bag
- 6.1.2.1.1. Glucose-Based Dialysate Bags
- 6.1.2.1.1.1. Glucose 1.5%
- 6.1.2.1.1.2. Glucose 2.5%
- 6.1.2.1.1.3. Glucose 4.25%
- 6.1.2.1.2. Icodextrin-Based Dialysate Bags
- 6.1.2.1.3. Amino Acid-Based Dialysate Bags
- 6.1.2.1.4. Bicarbonate-Based Dialysate Bags
- 6.1.2.2. Drainage Bag
- 6.1.2.3. Twin Bag
- 6.1.2.3.1. Glucose-Based Dialysate Bags
- 6.1.2.3.2. Icodextrin-Based Dialysate Bags
- 6.1.2.3.3. Amino Acid-Based Dialysate Bags
- 6.1.2.3.4. Bicarbonate-Based Dialysate Bags
- 6.1.3. Catheters
- 6.1.4. Transfer Set
- 6.1.5. Others
- 6.2. Services
- 7. China Peritoneal Dialysis Market Size By Dialysis Type (2019-2032)
- 7.1. Continuous Ambulatory Peritoneal Dialysis (CAPD)
- 7.2. Automated Peritoneal Dialysis (APD)
- 8. China Peritoneal Dialysis Market Size By Indication (2019-2032)
- 8.1. End-Stage Renal Disease (ESRD)
- 8.2. Acute Kidney Injury
- 8.3. Chronic Kidney Disease
- 9. China Peritoneal Dialysis Market Size By End User (2019-2032)
- 9.1. Hospitals
- 9.2. Dialysis Centers & Clinics
- 9.3. Homecare Settings
- 9.4. Others
- 10. China Peritoneal Dialysis Market Size By Provision
- 10.1. Hong Kong (SAR)
- 10.2. Shanghai (municipality)
- 10.3. Beijing (municipality)
- 10.4. Tianjin (municipality)
- 10.5. Jiangsu
- 10.6. Fujian
- 10.7. Guangdong
- 10.8. Zhejiang
- 10.9. Sichuan
- 10.10. Chongqing
- 10.11. Rest of China
- 11. Competitive Dashboard
- 11.1. Top 5 Player Comparison
- 11.2. Market Positioning of Key Players, 2024
- 11.3. Strategies Adopted by Key Players
- 11.4. Recent Developments
- 11.5. Company Market Share Analysis
- 12. China’s Top Company Profiles
- 12.1. Baxter International (Vantive)
- 12.2. Fresenius Medical Care
- 12.3. China Resources Double-Crane Pharmaceutical
- 12.4. Shandong Weigao
- 12.5. Changzhou Careu Medical Instrument
- 12.6. Medtronic
- 12.7. Becton Dickinson
- 12.8. Terumo Corporation
- 12.9. Nipro Corporation
- 12.10. Cook Medical
- 12.11. Huaren Pharmaceutical
- 12.12. Guangzhou Mecan Medical
- 12.13. Shijiazhuang NO.4 Pharmaceutical
- 12.14. Chengdu Qingshan Likang
- 12.15. Beijing DC-Pharma
- 12.16. Shanghai IVEN Pharmatech
- 13. Conclusion & Recommendation
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
